Can the Mirena (levonorgestrel-releasing intrauterine device (IUD)) cause hair loss in females?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Mirena Cause Hair Loss in Females?

Yes, the Mirena (levonorgestrel-releasing IUD) can cause hair loss in females, though it occurs infrequently with an estimated cumulative incidence of approximately 0.33% based on postmarketing surveillance data. 1

Evidence for Hair Loss Association

The most direct evidence comes from postmarketing surveillance:

  • The New Zealand Intensive Medicines Monitoring Programme identified 5 cases of alopecia associated with levonorgestrel IUD use, with a cumulative incidence of 0.33% (95% CI 0.07-0.95) among users. 1

  • The World Health Organization spontaneous reporting database contained an additional 68 reports of alopecia associated with the levonorgestrel IUD. 1

  • The study authors concluded that counseling prior to Mirena insertion should include information about the possibility of alopecia as a systemic side effect. 1

Mechanism and Context

The biological plausibility relates to the progestogenic effects of levonorgestrel:

  • Levonorgestrel is a synthetic progestogen that can have androgenic activity, and female pattern hair loss can be androgen-dependent in many cases. 2, 3

  • While the levonorgestrel IUD primarily acts locally in the uterus, systemic absorption does occur, which explains why systemic side effects including hair loss have been documented. 1

Clinical Implications

When a patient using Mirena presents with hair loss, consider the IUD as a potential contributing factor, particularly if the hair loss began after insertion and follows a diffuse pattern. 1

Key considerations include:

  • The hair loss typically manifests as diffuse thinning rather than a specific pattern. 1

  • Onset timing relative to IUD insertion is important for establishing causality. 1

  • Other causes of female hair loss should be evaluated, including thyroid dysfunction, iron deficiency, and other hormonal imbalances. 2, 4

Management Approach

If Mirena-associated hair loss is suspected:

  • Discuss IUD removal with the patient, as this addresses the underlying cause. 5 Fertility returns immediately after removal with no waiting period required. 6

  • Alternative contraceptive methods should be offered that may be less likely to cause hair loss. 5

  • If the patient wishes to continue the Mirena for its contraceptive or therapeutic benefits (such as heavy menstrual bleeding management), topical minoxidil 2-5% can be considered as treatment while maintaining the IUD. 2, 3, 4

Important Caveats

  • The incidence is low (less than 1% of users), so hair loss should not be assumed to be IUD-related without proper evaluation. 1

  • The benefits of Mirena for contraception and menstrual management are substantial, so the decision to remove should be individualized based on severity of hair loss and importance of the IUD's benefits. 5

References

Research

Hair loss in women.

Seminars in cutaneous medicine and surgery, 2009

Research

Female pattern hair loss: current treatment concepts.

Clinical interventions in aging, 2007

Research

Female Pattern Hair Loss-An Update.

Indian dermatology online journal, 2020

Guideline

Levonorgestrel Intrauterine Device (IUD) Contraception and Therapeutic Benefits

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

IUD Removal and Return to Fertility

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.